Pro Share Advisors LLC Bridge Bio Pharma, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 39,156 shares of BBIO stock, worth $2.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,156

Previous 39,020 0.35%

Holding current value

$2.21 Million

Previous $1.35 Million 25.37%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$30.14 - $45.12 $4,099 - $6,136	136 Added 0.35%	39,156 $1.69 Million
Q1 2025 May 08, 2025	SELL	$28.12 - $37.59 $267,674 - $357,819	-9,519 Reduced 19.61%	39,020 $1.35 Million
Q4 2024 Feb 13, 2025	BUY	$22.35 - $29.5 $242,810 - $320,488	10,864 Added 28.84%	48,539 $1.33 Million
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $251,007 - $328,587	10,498 Added 38.63%	37,675 $959,000
Q2 2024 Aug 13, 2024	SELL	$23.0 - $31.04 $140,392 - $189,468	-6,104 Reduced 18.34%	27,177 $688,000
Q1 2024 May 08, 2024	BUY	$27.35 - $40.45 $87,766 - $129,804	3,209 Added 10.67%	33,281 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $109,747 - $200,533	4,569 Added 17.92%	30,072 $1.21 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $3,766 - $7,807	223 Added 0.88%	25,503 $672,000
Q2 2023 Aug 10, 2023	BUY	$13.29 - $18.01 $30,885 - $41,855	2,324 Added 10.12%	25,280 $434,000
Q1 2023 May 11, 2023	SELL	$7.17 - $18.55 $21,725 - $56,206	-3,030 Reduced 11.66%	22,956 $380,000
Q4 2022 Feb 02, 2023	BUY	$6.74 - $11.52 $13,378 - $22,867	1,985 Added 8.27%	25,986 $198,000
Q3 2022 Nov 04, 2022	SELL	$7.94 - $12.36 $8,090 - $12,594	-1,019 Reduced 4.07%	24,001 $239,000
Q2 2022 Aug 01, 2022	SELL	$5.21 - $12.14 $65,734 - $153,170	-12,617 Reduced 33.52%	25,020 $227,000
Q1 2022 May 10, 2022	SELL	$7.34 - $17.16 $65,825 - $153,890	-8,968 Reduced 19.24%	37,637 $381,000
Q4 2021 Feb 08, 2022	SELL	$11.38 - $53.41 $20,097 - $94,322	-1,766 Reduced 3.65%	46,605 $778,000
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $298,702 - $409,401	-6,373 Reduced 11.64%	48,371 $2.27 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $409,958 - $563,990	8,822 Added 19.21%	54,744 $3.34 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $603,069 - $786,589	10,872 Added 31.02%	45,922 $2.83 Million
Q4 2020 Feb 09, 2021	BUY	$38.38 - $71.11 $245,785 - $455,388	6,404 Added 22.36%	35,050 $2.49 Million
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $17,571 - $27,254	-646 Reduced 2.21%	28,646 $1.08 Million
Q2 2020 Aug 03, 2020	BUY	$22.22 - $35.69 $175,404 - $281,736	7,894 Added 36.89%	29,292 $955,000
Q1 2020 May 15, 2020	SELL	$16.11 - $36.23 $135,130 - $303,897	-8,388 Reduced 28.16%	21,398 $621,000
Q4 2019 Feb 12, 2020	BUY	$17.96 - $46.63 $534,956 - $1.39 Million	29,786 New	29,786 $1.04 Million

Others Institutions Holding BBIO

# of Institutions

410

Shares Held

187M

Call Options Held

11.3M

Put Options Held

2.2M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $8.38B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Bridge Bio Pharma, Inc. Transaction History